Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.
about
A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivoProinflammatory role for let-7 microRNAS in experimental asthmaSplicing therapy for neuromuscular diseaseRole of CEACAM1 and CEACAM20 in an in vitro model of prostate morphogenesisGrowth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencingThe crystal structure of an 'All Locked' nucleic acid duplexTargeting Microtubules for Wound RepairEstablishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide DrugsSilencing disease genes in the laboratory and the clinicDelivery is key: lessons learnt from developing splice-switching antisense therapiesFrom the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro.Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.Evaluation of multiple-turnover capability of locked nucleic acid antisense oligonucleotides in cell-free RNase H-mediated antisense reaction and in mice.Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia modelRNAi and small interfering RNAs in human disease therapeutic applications.Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primatesInhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZOptimizing anti-gene oligonucleotide 'Zorro-LNA' for improved strand invasion into duplex DNA.Internalization of Locked Nucleic Acids/DNA Hybrid Oligomers into Escherichia coli.Antisense and antigene inhibition of gene expression by cell-permeable oligonucleotide-oligospermine conjugates.High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines.Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes.Identification of the endosomal sorting complex required for transport-I (ESCRT-I) as an important modulator of anti-miR uptake by cancer cells.Electroporation and microinjection successfully deliver single-stranded and duplex DNA into live cells as detected by FRET measurements.Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.Fibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary Blastoma.Stabilization of expanded (CTG)•(CAG) repeats by antisense oligonucleotides.Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides.Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomersTranscriptome dynamics of the microRNA inhibition response.mRNA fragments in in vitro culture media are associated with bovine preimplantation embryonic development.MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization.Ca2+ enrichment in culture medium potentiates effect of oligonucleotidesEnhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers.Male fertility status is associated with DNA methylation signatures in sperm and transcriptomic profiles of bovine preimplantation embryosShort-interference RNAs: becoming medicines.
P2860
Q21136366-BDF53683-DE90-405F-9A94-8C9D41EAD64AQ24604272-49819B7F-7AEC-4B17-9F84-EB1E58F5E46DQ27009581-1859AE91-26D4-434F-9B10-ED5EA889B2B1Q27321936-A169AEB7-C1CA-4042-AAF3-1B6334914E1EQ27322637-3B45AB9A-FC96-4C6C-991A-DE0074355106Q27662137-89C75279-AD66-4B5B-B038-CEA77BB0AC93Q28075978-0569308A-BAAB-4086-A291-E112F865BEF6Q28552808-A1A0B75F-AD20-4001-A0DE-81802E58A940Q29039090-450BDCE9-6A3C-4E71-9222-9AB2C7F56813Q33625875-0760C4C5-59C6-4A0A-957F-B9FE4C871390Q33632091-535E903F-A079-47CD-B1E6-B0A626DB910EQ33786263-C301C21A-F625-41AE-A36D-B488D54B416DQ33823337-11AEBAF4-4282-4BA8-81F5-A6566467A5A9Q33931423-6A0F88C4-5069-488E-BEE4-83584571EE2DQ34117470-5D0D31EC-5324-4FD1-A8D8-84B6735154D3Q34204092-0C9ACC4C-537C-423C-BE63-077B096F2A78Q34298059-9E0EE3F9-4078-4AB2-A3F9-C4BBF860BEBDQ34460507-EE7ECB0F-4345-4D61-A088-4DB0E04051E3Q34559630-6A0963D3-5EA2-4CA0-82FF-15A30FA659EAQ34628844-54C91E69-D930-46EE-A194-D83B7E3A1CE2Q35019418-9476FC1D-D6A0-4C30-8930-45BFBA525D2CQ35030106-87343302-2FD0-49DB-B219-C5CCFC228BA3Q35041004-24D3B441-76AD-4B45-B962-872E73A403B3Q35098066-04B95CC8-3EA1-4D09-8A29-6867EFA7445EQ35154985-931F6AA4-21B0-4400-932E-E7AD16C0DD2CQ35159206-990A8571-5B74-4ECD-8607-115F6FB676ADQ35182716-2DB64F6F-048C-4D28-A061-7AFFE77D1645Q35237068-79F6E048-C07F-4E51-A10F-2787CA55D138Q35610562-1201331A-2BC2-4F94-A141-6B81AAC49344Q35623474-F81C880C-B677-4F20-86CA-66A61E3F0D08Q35694248-FEB7B97F-2515-418D-9523-B526F945FC7FQ35747541-862017D6-EB01-48E5-8943-9A679E98D7F4Q35885964-648E0BD4-BF3B-4ADE-AC06-B6D18606CF18Q35989190-E4F09535-FF30-430C-9446-44DD91929605Q36051089-E70E73DF-5CC5-4BB2-8605-1D9BE6E56243Q36160667-CE59190E-F891-4136-9DFA-DC02CFE60721Q36228008-07A49C29-D8A4-49E6-842F-978C5D3FD0B6Q36228096-56A12646-43F9-4080-8574-0EF14F06224AQ36337141-7ABC5B12-1347-4F60-BD35-5D97F2D61F4FQ36347546-40B5D3D2-30CD-4535-A8DC-F101EAD77D73
P2860
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Efficient gene silencing by de ...... sted by transfection reagents.
@ast
Efficient gene silencing by de ...... sted by transfection reagents.
@en
Efficient gene silencing by de ...... sted by transfection reagents.
@nl
type
label
Efficient gene silencing by de ...... sted by transfection reagents.
@ast
Efficient gene silencing by de ...... sted by transfection reagents.
@en
Efficient gene silencing by de ...... sted by transfection reagents.
@nl
prefLabel
Efficient gene silencing by de ...... sted by transfection reagents.
@ast
Efficient gene silencing by de ...... sted by transfection reagents.
@en
Efficient gene silencing by de ...... sted by transfection reagents.
@nl
P2093
P2860
P356
P1476
Efficient gene silencing by de ...... sted by transfection reagents.
@en
P2093
Anatoliy Voskresenskiy
Daniella Castanotto
Harris S Soifer
Henrik Ørum
J Bo Hansen
Jesper Worm
Johnathan Lai
Luba Benimetskaya
P2860
P356
10.1093/NAR/GKP841
P407
P577
2009-10-23T00:00:00Z